MRSN icon

Mersana Therapeutics
MRSN

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$33
208% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Truist Securities
Truist Securities
Asthika Goonewardene
50% 1-yr MRSN win rate
14 Aug ‘25 2 months ago
Guggenheim
Guggenheim
Michael Schmidt
50% 1-yr MRSN win rate
14 Aug ‘25 2 months ago